About Index Trending news
Lists
Pricing
CEL-SCI Corporation

CEL-SCI Corporation

CEL-SCI Corporation

CEL-SCI's official Twitter handle. We are an immunotherapy company that focuses on unmet medical needs in oncology and infectious diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$3,500,000
Post-IPO equity
$1,000,000
Employees

Unknown size

Locations
HQ
$3,500,000 Post-IPO equity
Drug Delivery Business

Cel-Sci raises $3.5m for head and neck cancer immunotherapy

$1,000,000 Post-IPO equity
bizjournals , sec

Vienna’s Cel-Sci Corp. (NYSE MKT: CVM) raises $1 million for head and neck cancer trial - Washington Business Journal